Changes in Mf (A and B) CFA (C and D) prevalence at baseline, 1, 2 and 3 years after starting MDA. by Michael C. Payne (2664379)

Subjects:

Sentinel sites located within areas treated with MDA semiannually (solid red line) or annually (dashed blue line). by Michael C. Payne (2664379)

Subjects:

Directly observed antifilarial drug ingestion rates in semiannual and annual mass drug administration (MDA) areas. by Michael C. Payne (2664379)

Subjects:

Changes in circulating filarial antigen (CFA) prevalence and levels at years 1, 2, and 3 following the start of mass drug administration, with treatment given semiannually (2x/yr)... by Michael C. Payne (2664379)

Subjects:

SD under different weights. by Jianrong Cai (14245136)

Subjects:

Model framework. by Jianrong Cai (14245136)

Subjects:

Vehicle travel time. by Jianrong Cai (14245136)

Subjects:

SD under different penetration rates. by Jianrong Cai (14245136)

Subjects:

Notation description. by Jianrong Cai (14245136)

Subjects:

Five-stage speed adjustment. by Jianrong Cai (14245136)

Subjects:

Mean TTC under different weights. by Jianrong Cai (14245136)

Subjects:

SD and mean TTC under different weights. by Jianrong Cai (14245136)

Subjects:

Parameter values. by Jianrong Cai (14245136)

Subjects:

The statistical data of the partial graph. by Si Yu Zhao (19544793)

Subjects:

Experimental Design Flowchart. by Si Yu Zhao (19544793)

Subjects:

Effect of exogenous 1’,4’-<i>trans</i>-diol-ABA on the N6, tZr, tZ, and cZ content of HHZ and XLY900 at 24h under saline conditions. by Yin Jie (21464235)

Subjects:

Image 3_Significance of LRFN4 in prognosis and tumor microenvironment of lung adenocarcinoma.tif by Nana Wang (533812)

Image 2_Significance of LRFN4 in prognosis and tumor microenvironment of lung adenocarcinoma.tif by Nana Wang (533812)

Image 1_Significance of LRFN4 in prognosis and tumor microenvironment of lung adenocarcinoma.jpeg by Nana Wang (533812)

The Fig illustrates the effects of mutations on the stability, flexibility, compactness, and interactions of the AKT2-Ipatasertib complex through molecular dynamics simulations. by Sadia Afrin Runa (22504971)

Subjects: